T-group (topology)
5.1.5 8-bladed
Ligands and drugs
2,475
Member domains
587
with ligand contacts (≤ 4 Å)
23.7% of members
580
with DrugDomain annotations
23.4% of members
474
with a DrugBank compound
19.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5.1.5 belongs to X-group 5 beta-propeller-like, which binds 7.8 ligand superclasses per 20 proteins, broader than 52% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 236 |
| DB03205 | PQQ | Pyrroloquinoline Quinone | 87 |
| DB03469 | DHE | Heme D | 56 |
| DB03317 | HEC | Ferroheme C | 17 |
| DB08882 | 356 | Linagliptin | 6 |
| DB01261 | 715 | Sitagliptin | 5 |
| DB03660 | PHI | 4-Iodo-L-phenylalanine | 5 |
| DB04577 | 007 | 1-(1-phenylcyclopentyl)methylamine | 5 |
| DB04578 | 008 | (S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide | 5 |
| DB07482 | BPR | (2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE | 5 |
| DB08530 | SC3 | 7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE | 5 |
| DB08743 | XIH | 2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE | 5 |
| DB00123 | LYS | Lysine | 4 |
| DB00167 | ILE | Isoleucine | 4 |
| DB06203 | T22 | Alogliptin | 4 |
| DB07239 | 7AC | 7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile | 4 |
| DB07347 | AES | 4-(2-Aminoethyl)Benzenesulfonyl Fluoride | 4 |
| DB07412 | B2Y | 1-biphenyl-2-ylmethanamine | 4 |
| DB08588 | SY1 | 2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE | 4 |
| DB12625 | 8VU | Evogliptin | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 251 |
| CAmetal | CALCIUM ION | 90 |
| PQQ | PYRROLOQUINOLINE QUINONE | 88 |
| DHE | HEME D | 56 |
| NAmetal | SODIUM ION | 40 |
| CL | CHLORIDE ION | 27 |
| HEC | HEME C | 12 |
| TMO | trimethylamine oxide | 12 |
| 715 | (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE | 7 |
| 9XH | (2~{S})-2-azanyl-4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-1-(1,3-dihydroisoindol-2-yl)butane-1,4-dione | 7 |
| CW8 | (2S,4S)-1-[(2S)-2-amino-2-cyclohexylacetyl]-4-fluoropyrrolidine-2-carbonitrile | 7 |
| D06 | (2S)-2-amino-1-(1,3-dihydro-2H-isoindol-2-yl)-2-[(1r,4S)-4-(pyrrolidin-1-yl)cyclohexyl]ethan-1-one | 7 |
| GK2 | [(2~{R})-1-[(2~{R})-2-azanyl-3-methyl-butanoyl]pyrrolidin-2-yl]boronic acid | 7 |
| 356 | 8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione | 6 |
| CYN | CYANIDE ION | 6 |
| MGmetal | MAGNESIUM ION | 6 |
| LAmetal | LANTHANUM (III) ION | 5 |
| NO | NITRIC OXIDE | 5 |
| XIH | 2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE | 5 |
| 007 | 1-METHYLAMINE-1-BENZYL-CYCLOPENTANE | 4 |